KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Exact Sciences (EXAS) Cost of Revenue (2016 - 2025)

Exact Sciences has reported Cost of Revenue over the past 16 years, most recently at $288.5 million for Q4 2025.

  • Quarterly Cost of Revenue rose 17.99% to $288.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $992.1 million through Dec 2025, up 10.96% year-over-year, with the annual reading at $1.1 billion for FY2025, 17.45% up from the prior year.
  • Cost of Revenue was $288.5 million for Q4 2025 at Exact Sciences, up from $250.2 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $288.5 million in Q4 2025 and troughed at $110.0 million in Q1 2021.
  • The 5-year median for Cost of Revenue is $199.6 million (2023), against an average of $192.8 million.
  • Year-over-year, Cost of Revenue skyrocketed 150.12% in 2021 and then fell 25.78% in 2022.
  • A 5-year view of Cost of Revenue shows it stood at $119.1 million in 2021, then surged by 96.64% to $234.1 million in 2022, then decreased by 17.58% to $193.0 million in 2023, then rose by 26.72% to $244.5 million in 2024, then increased by 17.99% to $288.5 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Cost of Revenue are $288.5 million (Q4 2025), $250.2 million (Q3 2025), and $247.1 million (Q2 2025).